Adapt, which is based in Dublin, but operates out of Radnor, Pennsylvania, is one of a handful of companies that in recent years have introduced products
delivering naloxone, a decades - old drug that can quickly reverse an opioid overdose, in Narcan spray.
At an FDA advisory panel meeting in October 2016 to discuss appropriate
naloxone dosing, Seamus Mulligan, chief executive of Adapt Pharma Inc., said that «lower doses of
naloxone may
deliver too little
naloxone, too late.»